The industry-first sustainable charging solution enables quick installation at scale and easy expansion and maintenance to help meet growing demand...
ATLANTA--(BUSINESS WIRE)--#AzaleaHealth--Azalea Health Innovations Inc. (Azalea Health or Azalea), a leading provider of cloud-based patient management and health IT solutions,...
Announcement follows CHMP's previous decision to adopt a positive opinion recommending marketing authorization for Moderna's COVID-19 vaccine to include adolescents...
CAMBRIDGE, MA / ACCESSWIRE / February 24, 2022 / IIOT-OXYS Inc. (OTC PINK:ITOX) announces the execution of a Non-Disclosure Agreement...
Lynn Vos to remain on board of directors Besser brings 25 years of experience in life sciences, technology, capital markets...
Q4 2021 revenues of $7.2 billion; GAAP net-income of $4.9 billion and GAAP diluted EPS of $11.29Full year 2021 revenues...
WOBURN, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that its Quell wearable neuromodulation technology...
BEIJING, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of...
VANCOUVER, Feb. 24, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (NASDAQ, TSX: NVCN), will report financial results for...
Employee-led assessment affirms Chiesi USA’s strong performance in culture, leadership, values and trustCARY, N.C., Feb. 24, 2022 (GLOBE NEWSWIRE) --...
Rights Were Secured Pursuant to SMFL’s Acquisition of GSP Nutrition MIAMI, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Smart for Life, Inc....
Highlights: Strong business performance despite COVID-19 headwindsRevenue of $160.8 million in the fourth quarter and $690.6 million for the year...
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia,...
OT-101 is Oncotelic’s RNA Therapeutic Against TGF-βOT-101 has completed over six clinical trials against solid tumors with good efficacyOT-101 is...
In the press release published on February 22, 2022, the appendix with the notice was missing. The notice is attached...
The First and Only FDA-Approved, Ready-to-Use Oral Solution for the Acute Treatment of Migraine with or without Aura in Adults...
Revisiting the risk of tardive dyskinesia with metoclopramide use in diabetic gastroparesis: results of a real-world data driven epidemiology studySOLANA...
Newly published data demonstrates substantial cross-reactivity against multiple variants of COVID-19 S-only candidate is believed to be the first to...
REDWOOD CITY, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company developing innovative...
Appointment accelerates Company’s development roadmap in targeted therapies for neuropsychiatric disorders The Head of the Statistical Genetics Research Group at...